Oram Paul D, Strine Jeffrey
Department of Analytical Research, Merck & Co. Inc., P.O. Box 2000, Rahway, NJ 07065, USA.
J Pharm Biomed Anal. 2006 Mar 3;40(4):1021-4. doi: 10.1016/j.jpba.2005.08.006. Epub 2005 Nov 18.
The color of a powdered active pharmaceutical ingredient (API) in an investigational drug was found to be the result of a number of process parameters. Color measurements of the solid material were derived from reflectance data obtained from a sphere spectrophotometer. These data provided a convenient and non-destructive way to track the effects of variations to the process parameters on the resulting material. Visual evaluation could not provide an objective, quantitative assessment of the material. Color of solution (COS) measurements did not provide adequate sensitivity to distinguish some of the samples from each other, even when visual differences were apparent.
研究药物中活性药物成分(API)粉末的颜色被发现是多个工艺参数作用的结果。固体材料的颜色测量数据源自于通过球形分光光度计获得的反射率数据。这些数据提供了一种便捷且无损的方式,用于追踪工艺参数变化对最终材料的影响。目视评估无法对材料进行客观、定量的评估。溶液颜色(COS)测量对于区分部分样品之间的差异并不具备足够的灵敏度,即便目视差异明显时亦是如此。